Efficacy and Safety of Actovegin in Post-stroke Cognitive Impairment (PSCI)

PHASE3CompletedINTERVENTIONAL
Enrollment

503

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

November 30, 2014

Study Completion Date

November 30, 2014

Conditions
Post-Stroke Cognitive Impairment (PSCI)
Interventions
DRUG

Actovegin

Actovegin solution for infusion and Actovegin tablets

DRUG

Placebo

Actovegin placebo-matching solution for infusion and Actovegin placebo-matching tablets

Trial Locations (14)

Unknown

Nycomed Investigational Site, Grodno

Nycomed Investigational Site, Minsk

Nycomed Investigational Site, Vitebsk

Nycomed Investigational Site, Almaty

Nycomed Investigational Site, Barnaul

Nycomed Investigational Site, Irkutsk

Nycomed Investigational Site, Kazan'

Nycomed Investigational Site, Krasnoyarsk

Nycomed Investigational Site, Moscow

Nycomed Investigational Site, Novosibirsk

Nycomed Investigational Site, Saint Petersburg

Nycomed Investigational Site, Samara

Nycomed Investigational Site, Tomsk

Nycomed Investigational Site, Yekaterinburg

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Takeda

INDUSTRY